The stock of Physicians Realty Trust (NYSE:DOC) gapped down by $0.04 today and has $19.34 target or 8.00% below today’s $21.02 share price. The 8 months technical chart setup indicates high risk for the $2.83 billion company. The gap down was reported on Oct, 4 by Barchart.com. If the $19.34 price target is reached, the company will be worth $226.40 million less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. The stock decreased 2.41% or $0.52 on October 3, hitting $21.02. Physicians Realty Trust (NYSE:DOC) has risen 20.74% since March 1, 2016 and is uptrending. It has outperformed by 8.52% the S&P500.
Analysts await Physicians Realty Trust (NYSE:DOC) to report earnings on November, 4. They expect $0.28 earnings per share, up 7.69% or $0.02 from last year’s $0.26 per share. DOC’s profit will be $37.70 million for 18.77 P/E if the $0.28 EPS becomes a reality. After $0.22 actual earnings per share reported by Physicians Realty Trust for the previous quarter, Wall Street now forecasts 27.27% EPS growth.
Physicians Realty Trust (NYSE:DOC) Ratings Coverage
Out of 10 analysts covering Physicians Realty Trust (NYSE:DOC), 7 rate it a “Buy”, 1 “Sell”, while 2 “Hold”. This means 70% are positive. Physicians Realty Trust has been the topic of 15 analyst reports since August 10, 2015 according to StockzIntelligence Inc. The firm earned “Underweight” rating on Wednesday, December 9 by Morgan Stanley. The firm earned “Outperform” rating on Thursday, October 8 by FBR Capital. Stifel Nicolaus initiated the stock with “Buy” rating in Tuesday, December 8 report. The firm earned “Buy” rating on Thursday, December 31 by Stifel Nicolaus. SunTrust initiated Physicians Realty Trust (NYSE:DOC) on Monday, March 21 with “Neutral” rating. The firm has “Mkt Perform” rating by Raymond James given on Friday, September 2. The stock of Physicians Realty Trust (NYSE:DOC) has “Overweight” rating given on Thursday, December 17 by KeyBanc Capital Markets. The firm has “Buy” rating given on Friday, May 6 by Stifel Nicolaus. As per Tuesday, August 11, the company rating was maintained by Canaccord Genuity. The stock has “Buy” rating given by BTIG Research on Thursday, August 25.
According to Zacks Investment Research, “Physicians Realty Trust is a REIT. It is a self-managed healthcare real estate company engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company’s principal investments will include medical office buildings, outpatient treatment facilities, acute and post-acute care hospitals, as well as other real estate integral to healthcare providers. Physicians Realty Trust is based in Milwaukee, Wisconsin.”
Insitutional Activity: The institutional sentiment increased to 2.86 in 2016 Q2. Its up 0.54, from 2.32 in 2016Q1. The ratio increased, as 9 funds sold all Physicians Realty Trust shares owned while 42 reduced positions. 49 funds bought stakes while 97 increased positions. They now own 124.93 million shares or 23.40% more from 101.24 million shares in 2016Q1.
Bnp Paribas Inv Prtnrs owns 22,527 shares or 0% of their US portfolio. Geneva Advsrs Lc, a Illinois-based fund reported 1.13M shares. White Pine Lc holds 44,990 shares or 0.4% of its portfolio. Teacher Retirement System Of Texas accumulated 0% or 18,470 shares. The Massachusetts-based Panagora Asset Mgmt Inc has invested 0% in Physicians Realty Trust (NYSE:DOC). Balyasny Asset Ltd Com has 313,676 shares for 0.04% of their US portfolio. The Netherlands-based Pensionfund Dsm Netherlands has invested 0.06% in Physicians Realty Trust (NYSE:DOC). Great Lakes Advsr Ltd Liability Company reported 124,913 shares or 0.07% of all its holdings. Us Bank & Trust De last reported 30,514 shares in the company. Aqr Capital Mgmt, a Connecticut-based fund reported 182,530 shares. Amalgamated Comml Bank, a New York-based fund reported 14,509 shares. Lazard Asset Mngmt Ltd Liability Corp holds 0.01% of its portfolio in Physicians Realty Trust (NYSE:DOC) for 248,860 shares. Raymond James & Assocs holds 0.02% or 252,309 shares in its portfolio. Wellington Ltd Liability Partnership holds 0.01% of its portfolio in Physicians Realty Trust (NYSE:DOC) for 2.31 million shares. Barclays Plc reported 90,620 shares or 0% of all its holdings.
More notable recent Physicians Realty Trust (NYSE:DOC) news were published by: Forbes.com which released: “Ex-Dividend Reminder: Kite Realty Group Trust, Physicians Realty Trust and …” on September 30, 2016, also Streetinsider.com with their article: “Education Realty Trust (EDR) Adds Physicians Realty Trust’s Thomas as Director” published on October 03, 2016, Fool.com published: “Physicians Realty Trust: A High-Dividend Stock With Tremendous Upside Potential” on December 04, 2015. More interesting news about Physicians Realty Trust (NYSE:DOC) were released by: Businesswire.com and their article: “Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date …” published on September 26, 2016 as well as Businesswire.com‘s news article titled: “Physicians Realty Trust Announces $725 Million Pending Transaction with …” with publication date: April 05, 2016.
DOC Company Profile
Physicians Realty Trust, incorporated on April 9, 2013, is a healthcare real estate company. The Firm is engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company’s portfolio includes approximately 150 properties located in approximately 30 states with approximately 5,799,340 net leasable square feet.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.